King's College London

Research portal

The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)

Research output: Contribution to journalLetter

Standard

The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). / Russell-Jones, R; Powell, A-M; Acland, K; Calonje, E; O'Doherty, M; Healy, C.

In: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, Vol. 31, No. 2, 2005, p. 210-211.

Research output: Contribution to journalLetter

Harvard

Russell-Jones, R, Powell, A-M, Acland, K, Calonje, E, O'Doherty, M & Healy, C 2005, 'The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)', European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 31, no. 2, pp. 210-211. https://doi.org/10.1016/j.ejso.2004.10.009

APA

Russell-Jones, R., Powell, A-M., Acland, K., Calonje, E., O'Doherty, M., & Healy, C. (2005). The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 31(2), 210-211. https://doi.org/10.1016/j.ejso.2004.10.009

Vancouver

Russell-Jones R, Powell A-M, Acland K, Calonje E, O'Doherty M, Healy C. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2005;31(2):210-211. https://doi.org/10.1016/j.ejso.2004.10.009

Author

Russell-Jones, R ; Powell, A-M ; Acland, K ; Calonje, E ; O'Doherty, M ; Healy, C. / The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). In: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2005 ; Vol. 31, No. 2. pp. 210-211.

Bibtex Download

@article{0eecb885522e4502a9c580240e1a0214,
title = "The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)",
author = "R Russell-Jones and A-M Powell and K Acland and E Calonje and M O'Doherty and C Healy",
year = "2005",
doi = "10.1016/j.ejso.2004.10.009",
language = "English",
volume = "31",
pages = "210--211",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "2",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)

AU - Russell-Jones, R

AU - Powell, A-M

AU - Acland, K

AU - Calonje, E

AU - O'Doherty, M

AU - Healy, C

PY - 2005

Y1 - 2005

U2 - 10.1016/j.ejso.2004.10.009

DO - 10.1016/j.ejso.2004.10.009

M3 - Letter

C2 - 15698741

VL - 31

SP - 210

EP - 211

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 2

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454